NEW YORK (AP) — The Canadian drugmaker Valeant Pharmaceuticals International Inc. said Monday it approved an increase of $300 million in its program to repurchase shares, senior notes and other securities.
The Mississauga, Ontario, company said it the addition increases its buyback authority to up to $1.8 billion. Valeant said that under that authorization, it has bought back 15 million shares for $509.6 million, and $302.5 million in convertible …
Комментариев нет:
Отправить комментарий